No Increase in Surgical Deaths for New Med School Grads, Prescription for a Spanking, and Two Items on Pills

Comments (7)

Trackback URL | Comments RSS Feed

  1. Madeline says:

    Let’s see if I have this right. The new residents don’t kill you outright. They just kill you by giving you the wrong medication.

  2. Virginia says:

    drug appearance: My first thought was that differences have mainly to do with marketing. You would never allow a generic manufacturer to sell the same pill (in shape and color) as the name brand.

    worming: This sounds like exactly the same sort of worming (even the same drug!) that is used in cattle and horses. However, the problem remains largely the same: you have to give every animal a dose. Missing even one decreases the effectiveness of the treatment.

  3. Bruce says:

    Spanking is sometimes very effective therapy.

  4. Devon Herrick says:

    It is interesting how the cheap deworming drug for pets was found to be effective at preventing a disease that disabled large numbers of people. I watched a documentary about river blindness on PBS. Becoming blind in old age was more or less accepted as a given in these clan that lived near infected rivers.

  5. Buster says:

    The emergency room doctor had probably seen more than his fair share of kids who badly needed a spanking because their parents never bothered to discipline them.

  6. Serena says:

    I think I’d be wary of a drug that made my blog poisonous. I agree with Virginia, though, about the logistical difficulty of such a solution for malaria.

  7. John R. Graham says:

    The term for the shape, color, etc., of a pill is “trade dress,” and is a longstanding area of dispute between brand-name and generic drugmakers.

    Although I see that there is some confusion in some patients who switch to generic versions (after patent expiration) that is not a good enough reason for the government to take away the brand-name company’s trade dress, which is effectively trademark.

    Indeed, for some drugs (especially psychiatric drugs) the brand-name drug can keep significant market share after the patent expires. If patients and doctors want to keep using the brand-name version, despite its higher price, they should not be confused by a generic that looks the same.